Table 3 Treatment rate and the characteristics
Non-treatment | Treatment | P value | |
|---|---|---|---|
N (%) | 345 (32.0%) | 734 (68.0%) | < 0.0001 |
Sex | |||
male | 246 (33.0%) | 500 (67.0%) | |
female | 99 (29.7%) | 234 (70.3%) | 0.2910 |
Age (years) | |||
< 50 | 189 (58.7%) | 133 (41.3%) | |
50–60 | 90 (27.3%) | 240 (72.7%) | |
> 60 | 66 (15.5%) | 361 (84.5%) | < 0.0001 |
HbA1c (%) | |||
< 7 | 82 (28.4%) | 207 (71.6%) | |
7–10 | 153 (29.1%) | 372 (70.9%) | |
> 10 | 110 (41.5%) | 155 (58.5%) | 0.0010 |
T2DM duration (years) | |||
< 3 | 125 (50.4%) | 123 (49.6%) | |
3–10 | 151 (36.1%) | 267 (63.9%) | |
> 10 | 69 (16.7%) | 344 (83.3%) | < 0.0001 |
BMI (kg/m2) | |||
< 24 | 74 (25.5%) | 216 (74.5%) | |
≥ 24 | 271 (34.3%) | 518 (65.7%) | 0.0060 |
Hypertension | |||
Yes | 108 (20.9%) | 409 (79.1%) | |
No | 237 (42.2%) | 325 (57.8%) | < 0.0001 |
FLD | |||
Yes | 97 (33.9%) | 189 (66.1%) | |
No | 248 (31.3%) | 545 (68.7%) | 0.4110 |
ASCVD | |||
Yes | 33 (7.5%) | 407 (92.5%) | |
No | 312 (48.8%) | 327 (51.2%) | < 0.0001 |
DKD | |||
Yes | 84 (22.6%) | 288 (77.4%) | |
No | 261 (36.9%) | 446 (63.1%) | < 0.0001 |
DR | |||
Yes | 46 (19.4%) | 191 (80.6%) | |
No | 299 (35.5%) | 543 (64.5%) | < 0.0001 |
DPN | |||
Yes | 56 (17.6%) | 263 (82.4%) | |
No | 289 (38.0%) | 471 (62.0%) | < 0.0001 |
Lipid profile (mmol/L) | |||
TC | 4.32 ± 0.97 | 4.44 ± 1.31 | 0.0940 |
TG | 2.20 ± 1.66 | 2.13 ± 2.01 | 0.5750 |
HDL-C | 0.90 ± 0.17 | 1.05 ± 0.29 | < 0.0001 |
LDL-C | 2.52 ± 0.80 | 2.44 ± 1.05 | 0.1530 |